Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
obatoclax | apoptosis regulator bcl-2 | small molecule | Successful target | TTD , drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.45 | investigational,phase 2 | inhibitor |
obatoclax | apoptosis regulator bcl-2 | small molecule | Successful target | TTD , drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.45 | investigational,phase 2 | unknown |
obatoclax | apoptosis regulator bcl-xl | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.59 | phase 2 | unknown |
obatoclax | induced myeloid leukemia cell differentiation protein mcl-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.27 | phase 2 | unknown |
click here to return to the previous page |